| ||||||||||||||
|
|
|||||||||||||


Departments of *Anesthesiology,
Neuropsychology, and
Laboratory Medicine, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium
Address correspondence and reprint requests to Nagels Werner, MD, Department of Anesthesiology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium. Address e-mail to werner.nagels{at}skynet.be
We compared the effect of S(+)-ketamine to remifentanil, both in combination with propofol, on the neurocognitive outcome after open-heart surgery in 106 patients. A battery of neurocognitive tests was administered before surgery and 1 and 10 wk after surgery. Fourteen patients (25%) in the control group and 10 patients (20%) in the S(+)-ketamine group had 2 or more tests with a cognitive deficit (decline by at least one preoperative SD of that test in all patients) 10 wk after surgery (P = 0.54). Z-scores were calculated for all tests. No significantly better performance could be detected in the S(+)-ketamine group, except for the Trailmaking B test 10 wk after surgery. We conclude that S(+)-ketamine offers no greater neuroprotection compared with remifentanil during open-heart surgery.
IMPLICATIONS: N-methyl-D-aspartic acid receptors play an important role during ischemic brain injury. We could not demonstrate that S(+)-ketamine resulted in greater neuroprotective effects compared with remifentanil during cardiopulmonary bypass procedures when both were combined with propofol.
This article has been cited by other articles:
![]() |
C. Neuhauser, V. Preiss, M.-K. Feurer, M. Muller, S. Scholz, M. Kwapisz, M. Mogk, and I. D. Welters Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels Br. J. Anaesth., June 1, 2008; 100(6): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Szalma, A. Kiss, L. Kardos, G. Horvath, E. Nyitrai, Z. Tordai, and L. Csiba Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo. Ann. Thorac. Surg., October 1, 2006; 82(4): 1430 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shibuta, S. Varathan, and T. Mashimo Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide Br. J. Anaesth., October 1, 2006; 97(4): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Himmelseher and M. E. Durieux Revising a Dogma: Ketamine for Patients with Neurological Injury? Anesth. Analg., August 1, 2005; 101(2): 524 - 534. [Abstract] [Full Text] [PDF] |
||||
|